BST2 and carcinoma: The results of this study as summarized in our model (Figure 8) reveal the critical role of BST-2 in the many processes involved in mammary oncogenesis by showing that BST-2 expressed in carcinoma cells is a positive disease modifier and elevated levels of BST-2 predict tumor aggressiveness and host survival.